Literature DB >> 1654072

Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples.

S Gledhill1, A Gallagher, D B Jones, A S Krajewski, F E Alexander, E Klee, D H Wright, C O'Brien, D E Onions, R F Jarrett.   

Abstract

Thirty-five cases of Hodgkin's disease (HD) were analysed for the presence of Epstein-Barr virus (EBV) and human herpesvirus-6 (HHV-6) DNA. EBV genomes were detected in 11/35 cases while none of the cases was positive for HHV-6. Ten of the EBV-positive cases were subsequently analysed using a probe for the terminal region of the virus; the results suggested that the EBV-infected cells were clonally expanded. EBV subtypes specific DNA amplification was used to demonstrate that EBV subtype A, and not subtype B was present in the EBV-positive cases. The age distribution of the EBV-positive cases indicated a statistically significant trend for an increase in positivity with increasing age. This is the first indication that EBV is significantly associated with any subset of HD patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654072      PMCID: PMC1977506          DOI: 10.1038/bjc.1991.281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin's disease.

Authors:  C M Libetta; J H Pringle; C A Angel; A W Craft; A J Malcolm; I Lauder
Journal:  J Pathol       Date:  1990-07       Impact factor: 7.996

2.  Detection of a second widespread strain of Epstein-Barr virus.

Authors:  J W Sixbey; P Shirley; P J Chesney; D M Buntin; L Resnick
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

Review 3.  Genotypic analysis of lymph node biopsies.

Authors:  N T O'Connor
Journal:  J Pathol       Date:  1987-03       Impact factor: 7.996

4.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.

Authors:  C D Gregory; C Kirchgens; C F Edwards; L S Young; M Rowe; A Forster; T H Rabbitts; A B Rickinson
Journal:  Eur J Immunol       Date:  1987-08       Impact factor: 5.532

6.  Genomic analysis of the human B-lymphotropic virus (HBLV).

Authors:  S F Josephs; S Z Salahuddin; D V Ablashi; F Schachter; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

7.  Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin's and non-Hodgkin's lymphoma.

Authors:  S Gledhill; A S Krajewski; A E Dewar; D E Onions; R F Jarrett
Journal:  J Pathol       Date:  1990-07       Impact factor: 7.996

8.  The c-myc gene paradox in Burkitt's lymphoma chromosomal translocation.

Authors:  T H Rabbitts; R Baer; M Davis; A Forster; P H Hamlyn; S Malcolm
Journal:  Curr Top Microbiol Immunol       Date:  1984       Impact factor: 4.291

9.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

10.  A uniform deleting element mediates the loss of kappa genes in human B cells.

Authors:  K A Siminovitch; A Bakhshi; P Goldman; S J Korsmeyer
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

View more
  11 in total

1.  Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.

Authors:  Q Y Yao; D S Croom-Carter; R J Tierney; G Habeshaw; J T Wilde; F G Hill; C Conlon; A B Rickinson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy.

Authors:  Qian Tao; Jie Yang; He Huang; Lode J Swinnen; Richard F Ambinder
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 3.  Detection and characterization of Epstein-Barr virus in clinical specimens.

Authors:  R F Ambinder; R B Mann
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.

Authors:  A Claviez; M Tiemann; J Peters; H Kreipe; R Schneppenheim; R Parwaresch
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

5.  Association of Epstein-Barr virus with pediatric Hodgkin's disease.

Authors:  A A Armstrong; F E Alexander; R P Paes; N A Morad; A Gallagher; A S Krajewski; D B Jones; B Angus; J Adams; R A Cartwright
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

6.  11. Cancers attributable to infection in the UK in 2010.

Authors:  D M Parkin
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

7.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.

Authors:  A A Armstrong; L Shield; A Gallagher; R F Jarrett
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

8.  Association of HHV-6 with Hodgkin and non Hodgkin lymphoma.

Authors:  Hadis Kiani; Manoochehr Makvandi; Alireza Samarbafzadeh; Ali Teimoori; Niloofar Nisi; Hamide Mehravaran; Hashem Radmehr; Zeinab Hosseini; Azadeh Haghi; Toran Shahani; Mehran Varnaseri; Nastran Ranjbari
Journal:  Iran J Microbiol       Date:  2016-04

Review 9.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

Review 10.  Estimating the global burden of Epstein-Barr virus-related cancers.

Authors:  Yide Wong; Michael T Meehan; Scott R Burrows; Denise L Doolan; John J Miles
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-27       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.